Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/28/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Edgar L. Ross

Wrong Dr. Edgar L. Ross?

Director, Pain Management Center

Phone: (617) ***-****  
Email: e***@***.org
Local Address:  Massachusetts , United States
Brigham and Women's Hospital Inc
75 Francis St
Boston , Massachusetts 02115
United States

Company Description: Brigham and Women's Hospital (BWH) is a 793-bed non-profit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated...   more

Employment History

  • Attending Pain Management Physician
    Brigham and Women's Hospital Inc
  • Medical Director of Pain Management
    Brigham and Women's Hospital Inc
  • Director
    Pain Management Center at Brigham and Women's Hospital
  • Director
    Brigham and Women's Hospital Pain Management Center
  • Director, Hospital Pain Management Center
    Brigham and Women's Hospital Pain Management Center
  • Director of the Chronic Nociceptive Pain
    Brigham and Women's Hospital Pain Management Center


  • MD
  • M.D.
66 Total References
Web References
Edgar L. Ross, ..., 9 June 2015 [cached]
Edgar L. Ross, MD
Director, Pain Management Center, Brigham and Women's Hospital Associate Professor of Anaesthesia, Harvard Medical School
News Release - Visitor - Blue Cross Blue Shield of Massachusetts, 7 May 2012 [cached]
"Opioid medications are not the only method for treating and controlling pain, however when used appropriately they can truly make life more bearable for many people," said Dr. Edgar Ross, Medical Director of Pain Management at Brigham and Women's Hospital, and one of the outside experts who advised BCBSMA on its policies. "Blue Cross has offered a thoughtful plan that takes a balanced approach to ensure that these important medications are available, while at the same time emphasizing evidence-based practices to promote their safe use," he said.
Dr. Ross added, "The other important aspect of this plan is that it recognizes that a coordinated approach is necessary to prevent prescription opioid misuse, abuse and addiction.
Today's post is written by Dr. ..., 19 Nov 2013 [cached]
Today's post is written by Dr. Edgar Ross, Director of the Pain Management Center at Brigham and Women's Hospital (BWH).
Edgar Ross,fibromyalgia,irritable bowel syndrome,migraine headaches,Osher Center,pain management,restless legs syndrome,temporal mandibular joint dysfunction comments (0)
Living With Pain Becomes More Common, 21 April 2010 [cached]
According to Dr. Edgar Ross, director of the Brigham and Women's Hospital Pain Management Center in Boston, chronic nociceptive pain is the most common-it's pain from muscle or bone injuries.
Most chronic pain patients can be helped, according to Dr. Ross. He says that as many as 90% of patients who seek help at pain centers achieve pain reduction and improvement in function. He emphasizes that success in the treatment of chronic pain is defined by the ability of the patient to return to "regular life.
American RSDHope, 16 May 2006 [cached]
Edgar Ross, M.D., Director of the Brigham and Women's Hospital Pain Management Center in Boston, recently completed clinical trials testing the effectiveness of Ziconitide.He said that it is several thousand times more potent than morphine for pain, and appears to be safe when used long-term.In the trials Ziconitide, a protein, was injected into the patient's spine in combination with morphine.
A research team led by Edgar Ross, M.D. at the Brigham and Women's Hospital in Boston was recently involved in clinical trials on the drug PREGABALIN.The drug that reduces the pain and fatigue caused by fibromyalgia.While Dr. Ross says the results appear extremely promising, clinical trials have been temporarily put on hold due to some complications discovered in animal studies.A few of the mice from the early studies developed tumors which caused concern among the manufacturers of the drug and the FDA.Dr. Ross says the mice used in the study were a strain of mice at higher risk for tumors.While most drug companies have stopped using this type of mouse for their studies because of this reason, they were still used during the pregabalin studies.Dr. Ross says he remains optimistic about the drug's potential.
Other People with the name "Ross":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.